Overview

Study To Examine The Effects Of Lapatinib On The Pharmacokinetics Of Digoxin In Subjects w/ ErbB2 Positive Breast Cancer

Status:
Completed
Trial end date:
2009-07-10
Target enrollment:
Participant gender:
Summary
This is a two part study looking at the effect of lapatinib on concentrations of digoxin in the blood when both drugs are dosed together in Part 1; and looking at the safety and antitumor effect of lapatinib when used together with possible additional anticancer therapy as chosen at the doctor's discretion.
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Digoxin
Lapatinib